During the past decade, Debreceni Egyetem, Klinikai Kozpont, Onkologiai Klinika conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 5 clinical trials were completed, i.e. on average, 62.5% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 2 clinical trials were completed. i.e. 40% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Debreceni Egyetem, Klinikai Kozpont, Onkologiai Klinika" #1 sponsor was "Hoffmann-La Roche" with 3 trials, followed by "Genentech, Inc." with 2 trials sponsored, "Institut de Recherches Internationales Servier" with 2 trials sponsored, "BioNTech SE" with 1 trials sponsored and "Celldex Therapeutics" with 1 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Debreceni Egyetem, Klinikai Kozpont, Onkologiai Klinika" #1 collaborator was "Breast International Group" with 3 trials as a collaborator, "ADIR, a Servier Group company" with 1 trials as a collaborator, "Austrian Breast and Colorectal Cancer Group" with 1 trials as a collaborator, "BioNTech SE" with 1 trials as a collaborator and "Chiltern International Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Debreceni Egyetem, Klinikai Kozpont, Onkologiai Klinika" are "Breast Cancer" (4 trials), "Triple Negative Breast Cancer" (2 trials), "Carcinoma, Hepatocellular" (1 trials), "Carcinoma, Squamous Cell" (1 trials) and "Carcinoma, Squamous Cell of Head and Neck" (1 trials). Many other conditions were trialed in "Debreceni Egyetem, Klinikai Kozpont, Onkologiai Klinika" in a lesser frequency.

Most popular intervention types in "Debreceni Egyetem, Klinikai Kozpont, Onkologiai Klinika" are "Drug" (16 trials), "Biological" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Pertuzumab" (4 trials), "Placebo" (4 trials), "Trastuzumab" (4 trials), "5-Fluorouracil" (3 trials) and "Docetaxel" (3 trials). Other intervention names were less common.

The vast majority of trials in "Debreceni Egyetem, Klinikai Kozpont, Onkologiai Klinika" are 14 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Debreceni Egyetem, Klinikai Kozpont, Onkologiai Klinika". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Debreceni Egyetem, Klinikai Kozpont, Onkologiai Klinika, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Debreceni Egyetem, Klinikai Kozpont, Onkologiai Klinika, 2 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".